Dr Brewer's Friday Rant: The Solution To Clogged Arteries

Dr. Ford Brewer
23 Aug 202416:05

Summary

TLDRIn this impassioned transcript, the speaker, a content creator and healthcare professional, addresses the ongoing issue of heart disease as the leading cause of death in the U.S. Despite medical advancements, the speaker criticizes the reliance on statins and emphasizes the importance of metabolic disease management. They advocate for lifestyle changes and a better understanding of metabolic health, while also discussing the limitations of current medical practices in diagnosing and treating these conditions.

Takeaways

  • 📊 Heart disease, specifically coronary atherosclerosis, remains the leading cause of death in the United States for over two decades.
  • 🛡️ Atherosclerosis is largely preventable, yet it continues to be a top killer despite therapies aimed at lowering LDL levels, such as statins and PCSK9 inhibitors.
  • 🧬 The 'Four Horsemen of chronic disease' include heart disease, cancer, neurodegenerative disease, and metabolic disease, with heart disease being the most preventable.
  • 🤔 There is a debate within the medical community about the best approach to treating heart disease, with some focusing on lipidology and others on metabolic disease.
  • 💊 Statins have been widely used for decades but have not eliminated heart disease as the number one killer, suggesting a need to reevaluate their effectiveness.
  • 👨‍⚕️ The speaker advocates for a more lifestyle-focused approach to preventing heart disease, believing it to be more impactful than medication alone.
  • 👥 There is infighting within the medical community regarding the best strategies for preventing heart disease, with criticism between different factions.
  • 👂 The speaker emphasizes the importance of listening to patients' concerns and preferences when it comes to medication, such as statins.
  • 👶 A call to action for individuals to educate themselves about metabolic disease, as the medical community may not be fully equipped to diagnose or treat it.
  • 🧬 Familial hypercholesterolemia is a genetic condition that affects the metabolism of LDL and can lead to very high cholesterol levels, increasing the risk of heart disease.
  • 💊 Cyclodextrin and cavitex are mentioned as treatments that aim to remove cholesterol from the body, but the speaker expresses skepticism about their effectiveness based on current research.

Q & A

  • What was the main topic of the speaker's 'Ford's Friday morning rant'?

    -The main topic was the leading cause of death in the United States, focusing on heart disease and the role of LDL in atherosclerosis.

  • What is the 'Four Horsemen of chronic disease' the speaker mentioned?

    -The 'Four Horsemen of chronic disease' refer to heart disease, cancer, neurodegenerative disease, and metabolic disease.

  • Why does the speaker believe that heart disease is the most preventable among the 'Four Horsemen'?

    -Heart disease, specifically coronary atherosclerosis, is considered most preventable because it is caused by APO-containing lipoproteins, mainly LDL, which can be managed with therapies like statins and PCSK9 inhibitors.

  • What is the analogy the speaker uses to describe the differing perspectives in medicine today?

    -The speaker uses the analogy of the 'six Blind Men and the Elephant' to illustrate how different medical professionals may have varying and sometimes conflicting views on the same issue, like the nature of a disease.

  • What does the speaker suggest as a more effective approach than medication in managing heart disease?

    -The speaker suggests that lifestyle changes are much more important and effective in managing heart disease than relying solely on medications like statins.

  • Why does the speaker mention the importance of early management of blood pressure?

    -Early management of blood pressure is crucial to prevent the stiffening of arterial collagen, which can lead to increased pulse pressure and potentially contribute to heart disease.

  • What is the speaker's view on the use of high-dose statins?

    -The speaker does not recommend high-dose statins, preferring lower doses that manage cardiovascular inflammation more effectively.

  • What is the condition the speaker mentions that can cause heart attacks in teenagers?

    -The condition is homozygous familial hypercholesterolemia, a rare genetic disorder that leads to extremely high LDL cholesterol levels and an increased risk of heart attacks at a young age.

  • What is the speaker's stance on cyclodextrin and cavitex as methods for managing cholesterol?

    -The speaker is skeptical about the effectiveness of cyclodextrin and cavitex for cholesterol management, stating that while they are not dangerous, the evidence does not conclusively support their use for pulling cholesterol out of the body.

  • What advice does the speaker give to patients who are reluctant to take statins?

    -The speaker respects patients' decisions not to take statins, comparing the situation to a personal fight and positioning himself as a guide rather than a decision-maker, emphasizing the importance of individual choice.

  • What is the speaker's view on the medical community's ability to diagnose metabolic disease?

    -The speaker believes that the medical community, including family practitioners, cardiologists, and internists, often lacks the knowledge to accurately diagnose metabolic disease, which he sees as a significant problem.

Outlines

00:00

📰 CDC Mortality Report and Preventable Heart Disease

The speaker begins by discussing a CDC report on mortality data from 2023, highlighting heart disease as the leading cause of death in the United States for over two decades. The focus is on coronary atherosclerosis, which is responsible for most cardiovascular disease deaths. The speaker emphasizes the preventability of heart disease through lowering LDL levels, mentioning therapies like statins and PCSK9 inhibitors. However, they question why heart disease remains a top killer despite these therapies, suggesting a need to reassess the approach to prevention.

05:02

🤔 The Debate on Statin Usage and Metabolic Disease

The speaker delves into the debate surrounding the use of statins and the broader issue of metabolic disease. They express concern about the infighting within the medical community and the lack of consensus on the best approach to treating heart disease. The speaker advocates for a more significant focus on lifestyle changes as a preventative measure, arguing that medications have not been as effective as hoped. They also discuss their personal stance on statin use, recommending them for secondary prevention in patients with existing plaque but emphasizing the importance of individual choice and patient autonomy.

10:05

💊 Statin Dosing and the Importance of Lifestyle Changes

Continuing the conversation on statins, the speaker addresses questions from the audience about their use, side effects, and alternatives. They discuss their preference for lower dose statins for managing cardiovascular inflammation and their reluctance to use high-dose statins. The speaker also emphasizes the importance of lifestyle changes, such as exercise and diet, in preventing metabolic disease, and they express frustration with the lack of progress in this area despite decades of medication use.

15:07

🧬 Familial Hypercholesterolemia and Cyclodextrin

The speaker discusses familial hypercholesterolemia, a genetic condition that affects the metabolism of LDL cholesterol, and its implications for heart disease. They mention the development of therapies like PCSK9 inhibitors in response to this condition. The speaker also addresses questions about cyclodextrin and a product called Cavitex, which are being marketed as a means to remove cholesterol from the body. While they do not consider cyclodextrin to be dangerous, they express skepticism about its effectiveness based on the current state of research.

Mindmap

Keywords

💡Heart Disease

Heart disease, specifically coronary atherosclerosis, is the main topic of the video. It is defined as a condition where the arteries of the heart become clogged, leading to most cardiovascular disease deaths. The video emphasizes that heart disease has been the leading cause of death in the United States for the past two decades, highlighting the significance of prevention and treatment strategies.

💡Mortality Data

Mortality data refers to statistics related to death rates. In the context of the video, the CDC's National Center for Health Statistics released preliminary mortality data from 2023, which is used to discuss the prevalence of heart disease as the leading cause of death.

💡Atherosclerosis

Atherosclerosis is a medical term describing the process of plaque building up inside the arteries, which can restrict blood flow and lead to heart attacks and strokes. The video script discusses atherosclerosis as a major contributor to heart disease and emphasizes its preventability.

💡LDL

LDL, or low-density lipoprotein, is often referred to as 'bad cholesterol.' The script explains that LDL particles can penetrate artery walls and initiate atherogenesis. The video discusses therapies aimed at lowering LDL levels, such as statins and PCSK9 inhibitors, as a means to prevent atherosclerosis.

💡Statins

Statins are a class of drugs used to lower blood cholesterol levels and reduce the risk of cardiovascular diseases. The video mentions statins as a common therapy for lowering LDL levels, but also discusses the controversy and patient hesitancy regarding their use.

💡Metabolic Disease

Metabolic disease in the video refers to conditions arising from metabolic processes in the body, which can include diabetes, obesity, and cardiovascular diseases. The speaker suggests that focusing on metabolic health is crucial for preventing heart disease and criticizes the medical community's approach to diagnosing and treating these conditions.

💡Familial Hypercholesterolemia

Familial hypercholesterolemia is a genetic condition characterized by high levels of LDL cholesterol in the blood. The video script mentions it as a significant risk factor for heart disease, with some individuals having LDL levels significantly higher than normal due to genetic variations.

💡Prevention

Prevention is a key theme in the video, with the speaker advocating for a focus on lifestyle changes and metabolic health as opposed to solely relying on medication. The script discusses the importance of early intervention and management of conditions like pre-diabetes to prevent the progression to more severe diseases.

💡Cyclodextrin

Cyclodextrin is a compound that has been suggested for its potential to help remove cholesterol from the body. The video script mentions it in the context of a product called Cavitex, discussing its use and the skepticism around its effectiveness in treating plaque.

💡Pulse Pressure

Pulse pressure is the difference between systolic and diastolic blood pressure readings. The video script explains how pulse pressure can increase due to arterial stiffness, particularly with aging, and suggests managing blood pressure early in life as a preventative measure.

💡Lifestyle

Lifestyle is emphasized as a critical factor in preventing heart disease and metabolic conditions. The speaker argues that lifestyle changes are 'multiple times more important' than medication, urging viewers to take control of their health through diet, exercise, and other lifestyle interventions.

Highlights

Heart disease remains the leading cause of death in the United States for the last two decades.

Coronary atherosclerosis is the most preventable cause of cardiovascular disease death.

Therapies that lower LDL levels, such as statins and PCSK9 inhibitors, can prevent atherosclerosis.

Despite medical advancements, heart disease continues to be a top killer, indicating a need for better prevention strategies.

The importance of lowering LDL cholesterol as a preventive measure for atherosclerosis-related mortality is emphasized.

The analogy of the 'six blind men and the elephant' is used to describe differing perspectives in medicine.

Lipidologists and metabolic disease communities have contrasting views on the nature and treatment of heart disease.

The speaker criticizes the reliance on medications like statins for heart disease prevention, citing their limited effectiveness.

The speaker advocates for a greater focus on lifestyle changes as a more effective prevention method than medication.

The speaker discusses the challenges of diagnosing and treating metabolic disease in the current medical community.

Familial hypercholesterolemia is highlighted as a genetic condition often misdiagnosed, leading to high LDL levels.

The development of PCSK9 inhibitors is linked to the understanding of familial hypercholesterolemia.

Cyclodextrin and cavitex are discussed as substances with potential in cholesterol management, though not conclusively effective.

The use of cyclodextrin in delivering fat-based medications is explained, and its safety is confirmed.

The speaker expresses skepticism about the effectiveness of cyclodextrin-based products for cholesterol reduction.

A call to action for individuals to educate themselves about metabolic disease due to the medical community's limitations.

The transcript concludes with a discussion on the importance of managing blood pressure early to prevent arterial stiffness.

Transcripts

play00:00

the uh what what we're calling the

play00:02

Ford's Friday morning

play00:05

rant um and you know I'm not much of a

play00:09

Ranter um but I get emotional I you know

play00:14

as a content creator on YouTube I Follow

play00:18

other other healthc care uh and

play00:21

especially prevention content

play00:24

creators I've got this email in my uh

play00:28

inbox

play00:30

uh The Weekly Newsletter from one of

play00:32

them I'm not going to name the name many

play00:34

of you will recognize it as I get into

play00:36

it recently the cdc's I'm going to read

play00:39

it for for a second and then talk about

play00:41

it the cdc's national Center for Health

play00:44

statistics released its preliminary

play00:46

report on mortality data that's death

play00:49

rate data from

play00:51

2023 once again heart disease reigned

play00:55

Supreme as the leading cause of death in

play00:58

the United States it's a sorry

play01:01

distinction that it's held firmly for

play01:03

the last 20 years last two decades

play01:06

Health heart disease and more

play01:08

specifically coronary

play01:11

atherosclerosis uh clogging of the

play01:13

arteries of the heart which is

play01:16

responsible for the majority of deaths

play01:18

from cardiovascular disease is easily

play01:20

the most preventable of all the quote

play01:24

Four Horsemen of chronic

play01:27

disease many of you may know who I'm

play01:29

talking where this came from now um for

play01:32

example heart disease or that is heart

play01:35

disease cancer neuro degenerative

play01:38

disease and metabolic

play01:40

disease it is caused by APO containing

play01:44

lipoproteins 90 to 95% of which are

play01:49

LDL and uh which penetrate artery walls

play01:54

and initiate

play01:55

atherogenesis again plaque in the

play01:58

arteries thus therapies for lowering LDL

play02:02

levels such as statins pcsk9 Inhibitors

play02:07

and

play02:07

others have the power to virtually stop

play02:12

atherosclerosis in its

play02:14

tracts so why does this disease remain a

play02:17

top killer a study published last month

play02:20

provides some insights along with

play02:22

further evidence of the importance of

play02:24

lowering LDL as a means of preventing

play02:28

atherosclerosis related

play02:30

mortality you

play02:33

know I know I overuse the analogy of the

play02:36

six Blind Men and the Elephant but it's

play02:40

so

play02:42

so uh appropriate for what's going on in

play02:45

medicine today the um the

play02:50

lipidologists see and hear and feel

play02:53

LDL just like one of the Blind Men felt

play02:57

the elephant's tail and said this is a

play02:59

rope this disease is a rope but then

play03:02

you've got other folks who are up in the

play03:05

front feeling the trunk saying no no no

play03:08

this is uh this is like a snake this is

play03:11

not a rope it moves on its own and that

play03:14

may be the metabolic disease community

play03:17

in my perspective the metabolic disease

play03:19

Community is far more correct we've had

play03:24

decades what 50 years 40 Years of trying

play03:29

medic ations like

play03:31

statins as we continue to try Statin

play03:35

what has that done that Reliance on

play03:38

medications what has that done for heart

play03:39

attack and stroke I mean you read it

play03:42

right here it's still the number one

play03:44

killer I would agree it is

play03:48

preventable I wouldn't agree that it's

play03:50

easy but I would say that it's

play03:53

simple the patients that I see the folks

play03:56

that focus on metabolic disease that is

play03:59

is the issue an another concern that I

play04:03

have is again the fighting the the

play04:06

infighting the the backbiting that you

play04:09

have in our

play04:10

community on one side with the

play04:13

lipidologists uh you get a lot of uh of

play04:16

criticism of the low carb Community I

play04:19

was just out at low carb USA in San

play04:21

Diego got tons in tons of U criticism

play04:26

there because I do use STS uh I don't

play04:30

use high do statins my goal is not to

play04:33

Pound Down

play04:34

apob um and here's the thing given what

play04:38

I do I recommend statins for um people

play04:42

that have plaque already you're no

play04:44

longer a primary prevention patient

play04:46

you're a secondary preven prevention

play04:49

patient meaning you've got

play04:50

disease

play04:52

but uh at times in my practice I've had

play04:55

over 50% of my patients that had plaque

play04:58

say doc I know you would recommend it I

play05:01

know you use it yourself but I've heard

play05:03

a lot of bad things about statens I

play05:05

don't want to do that and I'm totally

play05:09

okay with that U my response is always

play05:12

that yep I'm okay with that you're L

play05:15

Luke Skywalker and and I'm Yoda so it's

play05:18

your fight I'm here to help I don't make

play05:21

all your decisions for you and here's

play05:24

the other thing about it I also feel

play05:26

like lifestyle is so much more important

play05:30

multiple times more important we've

play05:33

given statins and medications decades to

play05:36

fix this problem but they haven't done

play05:39

it on the other

play05:41

hand what have we done in terms of

play05:43

metabolic disease very very little and

play05:46

in fact we've gotten much much

play05:50

worse so I'm going to hold off on that

play05:52

and see if we have any uh comments or

play05:56

questions Cindy are you seeing any

play06:00

you are will you read read a couple to

play06:03

me no

play06:06

okay okay so hold on let

play06:09

me okay Sandra Bagwell you normally

play06:13

speak to heart and artery what do you

play06:15

think about dios Simon dios Simon for

play06:18

the Venus insufficiency and does Venus

play06:20

insufficiency go along with artery

play06:22

issues uh usually there are two very

play06:25

very different different issues um and

play06:29

I'm not familiar with uh

play06:32

Daimon Kyra 777 I'm back to the gym and

play06:36

walking very good thank you so much Kyra

play06:40

oh my gosh we got a lot of stuff here a

play06:42

lot of questions or a lot of comments

play06:45

Bibiana Bon hello Greg Strano what is

play06:49

pulse pressure and how do you reduce it

play06:52

so Greg pulse pressure is where you take

play06:54

the top number the systolic like

play06:57

hopefully 120

play06:59

and subtract the bottom number the

play07:02

diastolic uh hopefully 80 so if your

play07:05

blood pressure is 120 over 80 your pulse

play07:07

pressure is 120 minus 80 which is

play07:10

40 um when you so and you're asking how

play07:15

to reduce it here's one of the more

play07:17

common things that happens especially as

play07:19

we age the collagen the connective

play07:22

tissue in Our arteries like and like the

play07:24

big one in the the aorta it gets stiff

play07:28

so instead of pumping into a very soft

play07:31

flexible wall that expands to um to

play07:36

accommodate for the increased

play07:38

volume uh when you pump into a stiff uh

play07:41

artery the blood pressure shoots up so

play07:45

the biggest thing to do is not get old

play07:48

not get stiff collagen so and how do you

play07:51

do that one of the key things is

play07:53

managing your blood pressure early uh

play07:57

when in your 50s your 60s you start

play07:59

getting pre-diabetic uh starting to

play08:02

develop blood pressure problems is one

play08:04

of the most common causes or one of the

play08:07

most common causes for that that again

play08:09

goes

play08:10

unrecognized is undiagnosed pre-diabetes

play08:15

so we're having some problem holding the

play08:17

I'm going to have a next week I'm GNA in

play08:20

fact this week I got a little stand to

play08:23

hold my iPhone but I forgot it so we'll

play08:26

hopefully we'll have it ready for next

play08:28

week always heroic if you want to give a

play08:31

life advice to a teenager what would you

play08:34

give oh gosh hold

play08:37

your that's a good question I'm GNA have

play08:40

to think about that

play08:42

one Kyra 777 I'm on 80 milligrams of

play08:45

statins just had a bypass surgery I

play08:48

don't feel comfortable taking them any

play08:50

advice please well Kyra I can't advise

play08:54

you uh over the internet I will say I've

play08:57

been uh public before many many times I

play09:01

don't use high do statins um the the

play09:04

Statin that comes in 80 milligrams is

play09:07

the most common one is a lipor or a

play09:09

torvest Statin I don't use that one

play09:12

either I uh because it's not as quite as

play09:14

good at cardiovascular inflammation

play09:16

which is my major Focus point the lower

play09:18

dose statins do manage uh cardiovascular

play09:21

inflammation so I usually use 5

play09:23

milligrams of Crestor or um I use um

play09:29

another another one called paben or it's

play09:31

also the brand name is

play09:33

lavalo um again I can't advise you on

play09:37

what to take glad to hear you're back at

play09:40

the gym and walking

play09:41

though um orokin tablets can be taken

play09:46

instead of

play09:47

natto um I'm not familiar with oroy it

play09:51

sounds like it may be a brand of

play09:56

nyise um

play09:59

so let me see if there's anything else I

play10:01

want to respond to if not I'm going

play10:04

to to talk for a minute about

play10:09

cyclodextrin and

play10:12

cavitex before I do cap walks should I

play10:14

up my Statin dose I have PLA and take a

play10:16

low dose Statin I have zero side effects

play10:19

and I'm not a Statin hater oh and I'm

play10:22

very active well I mean again cap walks

play10:25

I I don't advise individuals on their

play10:28

care I think I just told you what I do

play10:30

in terms of

play10:34

Statin and Kyra yes I responded to your

play10:38

question Paulette Jackson I have

play10:41

familial hyper

play10:43

cholesterolemia found out I have severe

play10:45

mitro valve calcification I gladly went

play10:48

on 40 milligrams of Crestor have an echo

play10:51

study scheduled I'm

play10:53

77

play10:55

um poet thank you so much for sharing

play10:58

that um

play11:00

most folks are not aware of familial

play11:02

hyper cholesterolemia if you have an LDL

play11:05

of 180 or above you have a very good

play11:09

probability of having hyper cholesterol

play11:12

familial hyper cholesterolemia it's not

play11:14

just high cholesterol it's a genetic

play11:17

variation in which we can't we don't

play11:20

burn or metabolize our LDL as

play11:23

efficiently as most people do there are

play11:25

over

play11:26

2,000 uh genetic variations or SN IPS uh

play11:30

the the scientists call them that can

play11:34

cause this um the

play11:36

pcsk9 actually were developed out of a

play11:39

knowledge of this

play11:41

problem

play11:43

um I can tell you I've got a ton of

play11:46

patients with familial

play11:49

hypercholesterolemia uh most of them

play11:51

have LDL levels 180 to the low 200s now

play11:57

I can tell you that's what we call a

play11:58

garden variety or

play12:01

heterozygous uh familial

play12:03

hypercholesterol Amia that means you got

play12:04

that Gene that hyper cholesterol Gene

play12:07

from either your mom or your dad but you

play12:09

didn't get one from both of you from

play12:11

both of them that's about one in 300 to

play12:15

one 500 families now and and

play12:19

people now we know that cholesterol does

play12:23

matter because you have what we call

play12:28

homozygous uh familial hyper cholesterol

play12:30

Amia that's one

play12:33

in uh 300 * 300 or 500 * 500 it's very

play12:38

very rare I think it's about

play12:40

34,000 those people can have heart

play12:42

attacks in their teens in their early

play12:45

20s and teens and they have cholest LDL

play12:48

cholesterol not total LDL cholesterol in

play12:51

the

play12:52

500s so again we know that there's

play12:55

something going on with LDL it's just

play12:58

that the

play13:00

most of the existing medical community

play13:02

does not know how to diagnose metabolic

play13:04

disease that's not me just saying that

play13:07

that's clearly uh data from and evidence

play13:10

from Johns Hopkins from Mayo from plenty

play13:13

of other known academic medical

play13:15

institutions that just say look the

play13:18

docks that we're relying on to diagnose

play13:21

metabolic disease that is family

play13:22

practitioners

play13:24

cardiologists uh internists three4 of

play13:27

them don't know how to diagnose

play13:29

metabolic disease that's a big problem

play13:32

and in my mind that is the biggest

play13:34

problem that we have in at least in

play13:36

medicine today so don't depend on the

play13:39

medical community learn what you need to

play13:41

learn about metabolic disease I'm going

play13:44

to just make one more comment uh briefly

play13:47

about uh

play13:49

cyclodextrin uh before we wrap up today

play13:52

um I'm getting a lot of questions about

play13:55

it and it's like cyclodextrin are

play13:59

they're similar to the they're I think a

play14:03

polysaccharide uh they are similar to

play14:08

APO A1 and APO the proteins that form

play14:11

HDL and

play14:12

LDL why do I say that they have a side

play14:15

that we call lipophilic Fat loving and a

play14:18

side that we call hydrophilic water

play14:22

loving what has that geekiness got to do

play14:24

with anything well that's how you get uh

play14:28

cholesterol or

play14:30

triglycerides and water to mix so

play14:34

somebody put two and two together it's

play14:36

now a very very common way of delivering

play14:39

medications fat-based medications to the

play14:42

human body you see it with uh steroid

play14:44

pills you see it with a ton of things

play14:47

somebody got the big idea of saying

play14:49

let's give a lot of

play14:51

this as something that's going to pull

play14:54

cholesterol back out of the body uh I've

play14:57

seen a brand named C avidex recently and

play15:00

because one of my spaces is to talk

play15:03

about plaque uh I get question after

play15:06

question over the past few weeks because

play15:09

cedex has really started

play15:12

pushing uh their

play15:15

product um and what what do I think

play15:18

about it I think about it what I thought

play15:20

three or four years ago the the research

play15:23

the evidence hasn't changed very much it

play15:25

appeared

play15:27

optimistic but was it conclud Ive that

play15:29

this stuff's going to work no not at all

play15:32

um is the stuff dangerous cyclodextrin

play15:35

cavitex no it doesn't it's not it does

play15:38

not appear to be dangerous at all again

play15:39

it's used in multiple medications so if

play15:43

you want to pay thousands of dollars or

play15:44

hundreds of dollars and have what I hear

play15:47

what I just listened to was an enema

play15:51

using cyclodextrin cavitex then have at

play15:56

it

play15:59

see you next week

Rate This

5.0 / 5 (0 votes)

Étiquettes Connexes
Heart DiseaseHealth PreventionStatin TherapyMedical DebateLDL CholesterolAtherosclerosisMetabolic DiseaseHealthcare AdvocacyContent CreatorYouTube HealthMortality Data
Besoin d'un résumé en anglais ?